
Strategic Report
Chief Executive Officer’s Review
Our 21st year in business has been a ‘coming
of age’ moment: A year of accelerating
momentum, marked by a return to continuing
CCY revenue growth, decisive strategic actions,
and a clear validation of our long-term vision.
We have simplified our structure, sharpened
our focus on our key territories and brands,
and strengthened our financial foundations.
•
We delivered our first full year of Group
continuing CCY revenue growth since 2021,
supported by an encouraging second half
and clear exit momentum. This reflects the
impact of strategic changes across the
business, theresilience of our brands and
the work ofour dedicated teams.
•
We significantly simplified the Group.
Following the demerger of THG Ingenuity
at the start of the year, we completed
the disposal of Claremont Ingredients,
delivering a strong return on our investment
and accelerating progress towards a net
cash balance sheet.
•
THG Beauty delivered a robust second-half
recovery, reflecting our focus on prioritising
higher-margin territories and categories.
Concentrating resources where we have a
distinct advantage has delivered impressive
UK market share gains and returned the
business to revenue growth.
•
It was a landmark year for THG Nutrition,
where our strategy to build an omnichannel
presence is delivering phenomenal results.
I am particularly pleased with our offline
expansion, which is putting increasing
numbers of Myprotein products on shelves
and reaching millions of new customers.
•
Licensing agreements with category
leaders including Müller, Iceland and
Jimmy’s Coffee drove sales of over
43million Myprotein units into retail during
2025, extending the brand into new
categories and reinforcing our reputation
forquality and innovation.
•
We secured our long-term capital structure
by refinancing our debt facilities, materially
reducing gross debt while retaining the
liquidity to continue investing in the exciting
growth potential of our Beauty and Nutrition
businesses.
On remuneration, I am pleased to confirm
that, consistent with each of the past five
years since becoming a public company,
theExecutive Directors refused to accept any
salary increases during the 2025 financial
year. This approach has continued into 2026,
with no increases applied to either my role or
that of the Group’s CFO.
As has been my practice since IPO, I again
waived the maximum amount of my annual
salary permissible by law, resulting in me
receiving only the UK’s annual minimum wage.
Over the past five years, the cumulative value
of salary waived now totals £3.63m, before
taking into account bonus and share-based
awards that have also been waived during
thisperiod.
During 2025, the Group again made a
charitable donation equivalent to the value of
the salary I sacrificed in the year. The donation
supported the development of accommodation
for people experiencing homelessness
acrossManchester.
For the fifth consecutive year, the Executive
Directors also waived any participation in the
2025 annual bonus plan.
THG Beauty: Brand curation and
market leadership
Beauty retail has demonstrated both
disciplineand agility. A clear focus on
profitable sales and core UK and US markets
drove a strong return to growth in the second
half of the year, culminating in our strongest
Q4 revenue performance since Q4 2021. This
result reflects our commercial discipline and
commitment to progressing customer value.
The UK, our largest territory, was a standout
performer, with Lookfantastic delivering
exceptional growth and market share gains,
supported by our record-breaking Advent
season and the successful launch of over 80
new brands. This underscores our position as
the prestige beauty destination of choice for a
growing and increasingly loyal customer base.
Alongside driving our retail platforms, we
undertook a significant life cycle investment
across our own brand portfolio.
This was a deliberate programme to refine
formulations, enhance product appeal and
strengthen long-term brand positioning.
While this project constrained growth in parts
of the portfolio during the first half of the
year, the clear benefits were evident as the
year progressed. The successful relaunch
of the Ameliorate range and the improved
second-half performance at Perricone MD
demonstrate the value of this work. We also
expanded the reach of our luxury spa brand,
ESPA, by launching in over 100 M&S stores,
building greater brand visibility with a new
audience.
THG Nutrition: Accelerating
momentum through omnichannel
strategy
A fourth consecutive quarter of revenue
growth was delivered following the transitional
prior year and rebrand. While the year
presented challenges and margin pressure
with record whey commodity prices, we made
the strategic decision in the second half
to absorb some of these costs. This was a
deliberate choice to support our customers,
protect our market-leading position, and invest
in long-term loyalty and market share growth.
Our move into offline channels is transforming
the scale and awareness of Myprotein. From
a standing start only a few years ago, we now
have a presence in over 40,000 doors globally.
A cornerstone of this success is our ‘6-aisle
strategy,’ designed to integrate Myprotein into
every part of our customers’ daily lives and
shopping habits. This has been brought to life
through exciting collaborations with
category-leading partners. Our partnership
with global confectionery giant Mars allows
customers to enjoy iconic flavours in their
favourite protein products. In the freezer aisle,
our long-term partner Iceland expanded its
exclusive range to 25 innovative Myprotein
products, including high-protein ice creams and
even breakfast omelettes. Our collaboration with
Müller created the UK’s No.1 protein dessert,
and looking ahead, our recently announced
agreement with Greencore, a European leader
in convenience, will see Myprotein branded
food-to-go launch across major supermarkets.
“ A deliberate strategy to simplify the
Group, enhancing our operational focus
on the high-growth markets within
Beauty and Nutrition.”
THG PLC Annual Report and Accounts 2025
8